New Agreement with Mayo Clinic, page-2

This announcement shows the methodical long term approach the company is taking to ensuring it can increase its revenue base and derisk the company revenue streams.
The chronic heart failure market is considerably larger than the Lymphodema market and they are planning on having a market ready product this time next year...with clinical data to back up the product it will make the sales pitch a lot easier...
I believe this is a testament to the long term vision and leadership that our MD is showing and his experience with medtronic is clearly showing..
Build a market leading position and product, then clinically prove its worth. follow it up by making it the standard of care and then sell out to a major medical devices company once it is derisked...
All this takes time and money, but impeded are increasingly showing they are on the right path... and it looks like the persistent seller may have stopped.. time to resume the uptrend!